News Releases
Authority Magazine Interview
May 7, 2025 – Authority Magazine launched a new interview series highlighting tech leaders creating meaningful social and environmental change. As part of “Technology Making An Important Positive Social Impact,” Edward Pershing, Chairman of VisiRose, Inc. and CEO of Provectus Biopharmaceuticals, was interviewed about his company’s impact.
Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus’s Spinoff Company for Rose Bengal-Based Eye Drugs
January 14, 2025 – Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) today announced a $3 million seed financing round for VisiRose, Inc., Provectus’s Founded Entity that is developing novel ocular therapeutics.
VisiRose Announces $3 Million Seed Financing Round to Advance Ocular Therapeutics
January 14, 2025 — VisiRose Inc. today announced the closing of a $3 million seed financing round.
